Evidence map›Paper›PMID 22218094›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2012

BDNF Val66Met impairs fluoxetine-induced enhancement of adult hippocampus plasticity.

Kevin G Bath, Deqiang Q Jing, Iva Dincheva, Christine C Neeb, Siobhan S Pattwell, Moses V Chao, Francis S Lee, Ipe Ninan

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed
7.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 167 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Neurotrophin signalling in the human nervous system.Frontiers in molecular neuroscience · 2023
    Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Stress and Its Impact on the Transcriptome.Biological psychiatry · 2021
    Review

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Kevin G BathDepartment of Psychiatry, Weill Medical College of Cornell, New York, NY 10021, USA. Kevin_Bath@Brown.edu
Deqiang Q Jing
Iva Dincheva
Christine C Neeb
Siobhan S Pattwell
Moses V Chao
Francis S Lee
Ipe Ninan
Cornell University · USNew York University · US

Funding

MOLECULAR BIOLOGY OF THE NERVE GROWTH FACTOR RECEPTORR01NS021072 · NINDS · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI CHAO, MOSES VICTOR · 1985 to 2015
$5.8M
The Impact of the BDNF Val66Met Prodomain on Cognitive Function in a Mouse Model of Alzheimer's DiseaseR01NS052819 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI HEMPSTEAD, BARBARA L, LEE, FRANCIS SANG YONG · 2005 to 2019
$5.3M
Gamma-Secretase cleavage of the p75 receptorR01AG025970 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CHAO, MOSES VICTOR · 2006 to 2016
$3.3M
Developing Researchers in Neuropsychiatric ImagingR25MH060478 · NIMH · WEILL MEDICAL COLL OF CORNELL UNIV · PI CASEY, BETTY J · 1999 to 2008
$2.3M
Molecular Mechanisms of SSRI Action in Childhood and AdolescenceRC1MH088814 · NIMH · WEILL MEDICAL COLL OF CORNELL UNIV · PI LEE, FRANCIS SANG YONG · 2009 to 2010
$1.0M
Molecular Analysis of Neurotrophin ActionR56NS021072 · NINDS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CHAO, MOSES VICTOR · 2011 to 2017
$882k
Multidisciplinary Training in Development and LearningT32HD055177 · NICHD · CORNELL UNIVERSITY · PI FINLAY, BARBARA L · 2009 to 2013
$841k
NIA NIH HHS R01 AG025970NICHD NIH HHS HD055177NICHD NIH HHS T32 HD055177NIMH NIH HHS MH060478NIMH NIH HHS MH088814NIMH NIH HHS R25 MH060478NIMH NIH HHS RC1 MH088814NINDS NIH HHS NS052819NINDS NIH HHS NS21072NINDS NIH HHS R01 NS021072NINDS NIH HHS R01 NS052819NINDS NIH HHS R56 NS021072
6 · The paper itself

Abstract

Recently, a single-nucleotide polymorphism (SNP) in the brain-derived neurotrophic factor (BDNF) gene (BDNF Val66Met) has been linked to the development of multiple forms of neuropsychiatric illness. This SNP, when genetically introduced into mice, recapitulates core phenotypes identified in human BDNF Val66Met carriers. In mice, this SNP also leads to elevated expression of anxiety-like behaviors that are not rescued with the prototypic selective serotonin reuptake inhibitor (SSRI), fluoxetine. A prominent hypothesis is that SSRI-induced augmentation of BDNF protein expression and the beneficial trophic effects of BDNF on neural plasticity are critical components for drug response. Thus, these mice represent a potential model to study the biological mechanism underlying treatment-resistant forms of affective disorders. To test whether the BDNF Val66Met SNP alters SSRI-induced changes in neural plasticity, we used wild-type (BDNF(Val/Val)) mice, and mice homozygous for the BDNF Val66Met SNP (BDNF(Met/Met)). We assessed hippocampal BDNF protein levels, survival rates of adult born cells, and synaptic plasticity (long-term potentiation, LTP) in the dentate gyrus either with or without chronic (28-day) fluoxetine treatment. BDNF(Met/Met) mice had decreased basal BDNF protein levels in the hippocampus that did not significantly increase following fluoxetine treatment. BDNF(Met/Met) mice had impaired survival of newly born cells and LTP in the dentate gyrus; the LTP effects remained blunted following fluoxetine treatment. The observed effects of the BDNF Val66Met SNP on hippocampal BDNF expression and synaptic plasticity provide a possible mechanistic basis by which this common BDNF SNP may impair efficacy of SSRI drug treatment.

Indexed as

Analysis of VarianceAnimalsBiophysicsBrain-Derived Neurotrophic FactorBromodeoxyuridineDentate GyrusElectric StimulationEnzyme-Linked Immunosorbent AssayFluoxetineGene Expression RegulationGlial Fibrillary Acidic ProteinHumansIn Vitro TechniquesLong-Term PotentiationMaleMethionineBrain-Derived Neurotrophic FactorBromodeoxyuridineFluoxetineGlial Fibrillary Acidic ProteinMethionineReceptor, trkBSelective Serotonin Reuptake InhibitorsValine

Identifiers

PMID22218094
PMCPMC3306891
OpenAlexW2103587403

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.